Search Results 7041-7050 of 25433 for oral
Genetic-Guided Oral P2Y(12) Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2023 Apr 10 ...
... oral acetaminophen and nonsteroidal anti-inflammatory drugs) * Have any condition requiring systemic treatment with corticosteroids, prednisone equivalents ...
No patients with known actionable EGFR mutations (except exon 20 insertion), ALK or ROS1 mutations that can be treated with oral tyrosine inhibitors.
Inadequate response to an adequate course of appropriate oral antibiotics for treatment of HS in the last 1 year, as per investigator discretion. This is ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
Previous exposure to carisbamate or sensitivity/allergy to components of the oral suspension. Note: Other protocol defined Inclusion/Exclusion Criteria may ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine in Minnesota · Sleep Medicine · Sleep Surgery Clinic ...
The risk typically arises from clots that may form in the left atrial appendage. Lifelong treatment with warfarin blood-thinning therapy or a direct oral ...
Patients with any condition that may impair the ability to absorb oral medications/investigational product including: Prior surgical procedures affecting ...
Immunosuppressive or immunomodulating treatment, including chronic oral or IV steroids, must be discontinued at least 4 weeks prior to screening. History of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.